Fetal and Neonatal Heart Monitor Market: Forecast, Trend Analysis and Competition Tracking: Global Review 2018 to 2028

Global sales of fetal and neonatal heart monitors are likely to surpass 261,000 units in 2018, with rising adoption in the US driving sales. Cardiotocographs remain the highest selling fetal and neonatal heart monitor devices, with global sales equating a valuation of nearly US$ 400 Mn in 2017. Demand continues to remain concentrated in hospitals and neonatal clinics, with the former accounting for a leading share.

Request For Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=750

The fetal and neonatal heart monitors continues to be driven by efforts to mitigate the number of preterm births. Data from National Center for Health Statistics shows that the US has a high infant mortality rate among developed economies. The number of deaths per live births also remains a concern in Europe, with governments and healthcare providers in the United Kingdom, France, Germany, and Italy working towards mitigating the numbers.

The report finds that Asia Pacific excluding Japan (APEJ) will emerge as a lucrative market for fetal and neonatal heart monitor manufacturers during the assessment period. Many countries in the region have high infant mortality rates, and there has been a concerted effort by governments and healthcare providers to improve the situation.

Use of fetal and neonatal heart rate monitors is also growing on account of increase in the number of NICU admissions. The growing applications and deployment of monitoring technologies in NICUs is likely to foster the growth of the fetal and neonatal heart monitor market during the assessment period. The increase in the number of NICUs is also opening opportunities for key players in the market. The report finds that high preterm birth rates in developing countries, such as India has led to opening of new NICUs, which in turn has created opportunities for the deployment of fetal and neonatal heart monitors.

Although the outlook on the fetal and neonatal heart monitor market remains positive, challenges with performance and false results continue to impede growth. Challenges with wrong heart rate tracking can lead to wrong readings, which in turn can lead to ambiguity. In a bid to address these challenges, manufacturers are focusing on launching innovate and novel products in the market. Philips Avalon has developed smart pulse fetal monitoring technology that uses cross channel verification for ensuring right results. The report opines that manufacturers will continue to focus on research and development to create product differentiation in the market.

Opportunities Abound in Fetal and Neonatal Heart Monitors for Metabolic Disorder Induced Risks

Despite intensive efforts taken for interpretation of fetal and neonatal heart rate to prevent hypoxia, challenges prevail regarding complete diagnosis of heart rate pattern changes, particularly caused by metabolic disorders. New research approaches are being introduced for facilitating care of fetal and neonatal hypoxia cost-effectively, as a means to alleviate expensive and complication procedure related to computerized Cardiotocograph (CTG).

One of these approaches is to assess mobile resuscitation devices, which are particularly designed for simplifying newborn resuscitation at bedside through an intact cord, as iatrogenic interference with “auto-resuscitation” occurs post-separation of newborn babies from their placental transfusion. Another effective approach the use of CO breath analyzers during the period of labor, which is easy-to-use, speedy, and non-invasive technology. This technology enables identifying most frequent conditions causing metabolic academia and hypoxia.

Vested interest and rigid mindset of equipment manufacturers who seek lucrative medico-legal practices point at over-longstanding dependency on CTG. However, new research approaches being introduced have paved new avenues for manufacturers of fetal and neonatal heart monitor.

Browse Full Report with TOC @https://www.factmr.com/report/750/fetal-and-neonatal-heart-monitor-market

Fetal and Neonatal Heart Monitor: Novel Modality Developments Offering Framework for Non-Invasive Evaluation

Healthcare professionals recommend intrapartum fetal heart rate (FHR) monitor during labor for proper assessment of fetal wellbeing. Despite high penetration, fetal scalp electrode monitor and external Doppler have been deemed to have significant shortcomings, which in turn has led toward the development of non-invasive modality technologies as possible alternatives. Intrapartum fetal heart rate monitoring using Electronic Uterine Monitoring (EUM) is considered to be a notable development in the field.

Comparative analysis carried out between accuracy of FHR trace via novel EUM, and fetal scalp electrode monitor and external Doppler has shown accuracy of the former to be significant higher. Intrapartum FHR via EUM has been proved to be accurate and valid, offering higher yields in correlations with the internal scalp electrode monitoring and external Doppler. Such novel modality developments are likely to impart greater framework for intrapartum FHR’s non-invasive evaluation.

Check Discount @ https://www.factmr.com/connectus/sample?flag=D&rep_id=750

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare MarketResearch Reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/Get More Industry Insights At: https://www.linkedin.com/company/factmr

This release was published on openPR.